Imidazole → 5-tert-Butyl-2-(3-triisopropylsilanyloxy-phenyl)-2H-pyrazol-3-ylamine
Reaction equation
[CH:1]([Si:4](Cl)([CH:8]([CH3:10])[CH3:9])[CH:5]([CH3:7])[CH3:6])([CH3:3])[CH3:2].[NH2:12][C:13]1[N:17]([C:18]2[CH:19]=[C:20]([OH:24])[CH:21]=[CH:22][CH:23]=2)[N:16]=[C:15]([C:25]([CH3:28])([CH3:27])[CH3:26])[CH:14]=1.N1C=CN=C1>CN(C=O)C>[C:25]([C:15]1[CH:14]=[C:13]([NH2:12])[N:17]([C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([O:24][Si:4]([CH:8]([CH3:10])[CH3:9])([CH:5]([CH3:7])[CH3:6])[CH:1]([CH3:3])[CH3:2])[CH:19]=2)[N:16]=1)([CH3:28])([CH3:26])[CH3:27]Participants
5
Procedure
Triisopropylsilylchloride (1.02 mL, 3.96 mmol) was added to a solution of 3-(5-amino-3-tert-butyl-pyrazol-1-yl)-phenol (915 mg, 3.96 mmol) and imidazole (646 mg, 9.50 mmol) in DMF (15 mL) at 0° C. The reaction was stirred at RT over the weekend then partitioned between EtOAc and water. The aqueous layer was then extracted with EtOAc (3×). The combined organic layers were washed with brine, dried (MgSO4), filtered and evaporated in vacuo. The residue was purified by FCC, using 0-40% EtOAc in cyclohexane, to give the title compound (1.53 g, 99%). LCMS (Method 4): Rt 4.78 min, m/z 388 [MH+].
Workup
- customthen partitioned between EtOAc and water
- extractionThe aqueous layer was then extracted with EtOAc (3×)
- washThe combined organic layers were washed with brine
- dry with materialdried (MgSO4)
- filtrationfiltered
- customevaporated in vacuo
- customThe residue was purified by FCC
Sources & evidence
- ORD record
- ord-2f5bd3442d214e6f991724730827f825
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08835431B2
Reaction notes
Loading…